Navigation Links
Sigma-Aldrich Names Patrick Sullivan New VP of Research and Development for Research Biotech
Date:9/27/2007

ST. LOUIS, Sept. 27 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) is pleased to announce that Patrick M. Sullivan has been named the Vice President of R&D for the Research Biotech business unit, effective October 1, 2007. In this role, he will help expand Sigma-Aldrich's leadership position through the development of new and innovative products for life science researchers. Sullivan has been involved with Sigma-Aldrich since 2005 as a member of the Company's Scientific Advisory Board, where he provided a large pharmaceutical perspective on new strategic plans and product offerings in the Company's Research Biotech business unit. Sullivan will report directly to David A. Smoller, Ph.D., President of Research Biotech.

Pat Sullivan has over 19 years of experience using and developing genomic-based solutions for the pharmaceutical and biotech industries. He was employed by Monsanto/Searle/Pharmacia for 12 years, where he provided molecular biology support for Inflammation and angiogenesis new target/biomarker discovery projects. He joined Incyte Genomics in 2000 as the Vice President of Global Operations, responsible for managing all genomic products and services. Most recently, Sullivan was employed by Pfizer, where he led efforts to identify new therapeutic opportunities in osteoarthritis and cardiovascular diseases.

"We are pleased to have such an strong and experienced leader join our organization," said David A. Smoller. "Patrick's combination of technical expertise, strong ability to analyze complex business operations and implement strategies to improve performance will be an immediate asset to our Research Biotech business unit's mission of bringing innovative technologies and solutions to life science researchers. We look forward to having him join us in making these valuable contributions to our life science community."

Sullivan received his B.S. degree in Microbiology from Western Illinois University and his M.S. degree in Mo
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Wisconsin IT association names Gee president, CEO
2. Quintessence Biosciences names new president
3. CDW names VP to handle Berbee merger
4. NimbleGen names CFO with capital-raising past
5. Cisco names Berbee a top partner of 2005
6. Cisco names Inacom most innovative partner
7. UW-Madison medical school names new dean
8. GE Healthcare names new CEO
9. Bruker AXS names new leadership
10. Sonic Foundry names new senior vice president
11. MyWeather names new president, marketing officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...T, Israel and JERSEY CITY, New Jersey, July 3,/PRN...: ROSG ), a leading,developer of microRNA-based d...ll present Collins Stewart Fourth Annual Growth Co...he Mandarin Oriental Hotel in New,York., About Ro... is a leader in the field of microRNA.,Founded in ...
(Date:7/2/2008)..., Austria, July 3 /- Nabriva Therapeu...ounces that Dr. George Golumbeski,has been appoint.... Golumbeski brings to the team nearly twenty year...Vice President of Business Development,Licensing ...tis. In this,position he was responsible for the f...
(Date:7/2/2008)...E V, Only Drug Eluting Stent to Demonstrate Superi..., Now Available in United States for ...PARK, Ill., July 2 /- Abbot...nistration (FDA) approved the,XIENCE(TM) V Everoli...t of,coronary artery disease. XIENCE V is the only...
(Date:7/2/2008)... Moore named as Vice President, Marketing and Sale..., Corporate Development, PT. RICHMOND, Calif., Ju...c. today announced the appointment of Terrence Moo...d Sales and Susan Koppy to the position of Vice,Pr... Ms. Koppy will report,to President & Chief Execut...
Breaking Biology Technology:Nabriva Therapeutics Announces Appointment of New CEO 2FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 2FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 3FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 4FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 5Transcept Pharmaceuticals Appoints Key Senior Executives 2Transcept Pharmaceuticals Appoints Key Senior Executives 3Transcept Pharmaceuticals Appoints Key Senior Executives 4
...rms that use slogans and catchy buzz-phrases to ca...ve ear of executive management. Economic developme... those slogans. , ,When a slogan or phrase rings ...des faster than the T-shirts and hats it is printe...ecause future economic viability is going to hinge...
...n Milwaukee and perhaps throughout Wisconsin will ... digital inclusiveness as Milwaukee moves toward c... ,The City of Milwaukee , having finalized a cont... citywide wireless Internet network, will pursue f...ide, including the provision of low-cost or refurb...
...nd in city and state government is joining a new g...o attract federal grant money for start-up bioscie...Wisconsin lobbying firm Hamilton Consulting Group.... Sanders will focus on Hamilton,s new government ... in collaboration with the national economic devel...
...oping diagnostics to test for kidney disease is pr...ts to secure federal clearance for its first clini...a total of $3.2 million since its inception in 199... round for additional product research and develop...sed NEW Capital Fund , and also included Wisconsi...
Other Biology Technology:Locations must have connectivity to be viable 2Locations must have connectivity to be viable 3Locations must have connectivity to be viable 4Businesses could bridge digital divide in Milwaukee with used computers 2Businesses could bridge digital divide in Milwaukee with used computers 3Renovar captures $1.2M for product development 2
(Date:7/3/2008)...GE, Mass., July 3, 2008 -- Sirtris, a GlaxoSmithKl...small molecule drugs to treat diseases of aging su...h team that reported in today,s online edition of ...to the end-of-life with resveratrol showed an over...alth, a reduction in cataracts and cardiovascular ...
(Date:7/3/2008)...bservation satellites have provided vital informat...icularly long crisis response window following the...n 2 and 3 May 2008. , Immediately after the disa...tarian Affairs (OCHA) asked the International Char... ,the Charter, for support by providing immediate...
(Date:7/3/2008)... TexasA dynamic way to alter the shape and size of...t of proteins has been developed by biological che...ryan Kaehr at The University of Texas at Austin. ,...d three-dimensional microstructures, known as hydr...d the hydrogels by altering the chemistry of the e...
(Date:7/3/2008)... Moines, Iowa July 3, 2008 Endangered wild orang...harply in Sumatra and Borneo than previously estim...th by Great Ape Trust of Iowa scientist Dr. Serge ...Oryx The International Journal of Conservation . ...f orangutans, found only on the islands of Sumatra...
Breaking Biology News(10 mins):Long-term study of middle-aged mice shows 2Long-term study of middle-aged mice shows 3Extended cyclone relief efforts aided from space 2Extended cyclone relief efforts aided from space 3'Smart' materials get smarter with ability to better control shape and size 2'Smart' materials get smarter with ability to better control shape and size 3Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 2Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 3Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 4Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 5Scientists uncover the potential to control adult stem cells 2841 1Scientists uncover the potential to control adult stem cells 2841 2Consumerism Driving Healthcare Change 16463 1Consumerism Driving Healthcare Change 16463 2Loma Linda University Partners With Larta Institute for Technology Marketing Program 4519 1Loma Linda University Partners With Larta Institute for Technology Marketing Program 4519 2Postmenopausal Womens Sexual Dissatisfaction Not Linked to Heart Troubles 16462 1Postmenopausal Womens Sexual Dissatisfaction Not Linked to Heart Troubles 16462 2
...dresses western medicine & society,s embrace o...ns Medical Dean Edward Miller, and Georgetown Univ... With Western medicine,s increasing interest in me...g, the Mind & Life Institute, in partnership w...the Johns Hopkins University School of Medicine wi...
...ound in the Welsh national flower, which could off...eing supported for large scale manufacture by Card...(MEC). , Alzheimer,s disease is the most common fo... of dementia. Dementia affects one person in 20 ov...ge of 80. , Certain species of daffodil, which th...
... Florida researchers say they are a step closer to...ncers before symptoms become apparent. , The findi...tional Academy of Sciences, involve introducing mo...ures and observing whether they unleash a fluoresc..., The technique could enable doctors to search wit...
...t Stanford University have created a larger-than-n...ently as natural DNA. The findings, reported in th... National Academy of Sciences (PNAS), may reveal n...es that occur during DNA replication-arise. The di... professor of chemistry at Stanford and co-author ...
Other Biology News:Dalai Lama, top scientists to discuss science & clinical applications of meditation 2Dalai Lama, top scientists to discuss science & clinical applications of meditation 3Scientists closer to new cancer detection method 2Scientists closer to new cancer detection method 3DNA size a crucial factor in genetic mutations, study finds 2DNA size a crucial factor in genetic mutations, study finds 3